Scientists at Ben Gurion University have slowed the progress of ALS (Lou Gehrig’s). They used part of the FDA-approved cancer / autoimmune disease treatment MabThera (Rituximab) to combat glial cells, which kill the body’s motor neuron cells.  It may also treat other brain diseases.

http://www.timesofisrael.com/israeli-scientists-announce-new-treatment-for-als/

https://aabgu.org/bgu-develops-new-drug-therapy-for-als-patients/